Humankind Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Humankind Investments's ARKG Position: Q2 2026 in Review
Humankind Investments held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 386,000 shares worth $16.2M. The position accounts for 7.76% of the portfolio, ranked #6.
Humankind Investments first reported a position in ARKG in Q1 2026 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Humankind Investments held 386,000 shares of ARK Genomic Revolution ETF worth $16.2M as of Q2 2026.
- Humankind Investments left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
- ARK Genomic Revolution ETF made up 7.76% of Humankind Investments's portfolio in Q2 2026, its #6 holding.
- Humankind Investments first reported a position in ARK Genomic Revolution ETF in Q1 2026 and has held it in 2 quarters since.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Humankind Investments's 13F filing for Q2 2026, filed 14 Aug 2026.